Published in Mol Cell Biol on January 01, 1984
Cloning, sequencing, and functional analysis of oriL, a herpes simplex virus type 1 origin of DNA synthesis. Mol Cell Biol (1985) 4.14
Roles of the 2 microns gene products in stable maintenance of the 2 microns plasmid of Saccharomyces cerevisiae. Mol Cell Biol (1987) 1.44
Behavior of a Drosophila melanogaster transposable element in Saccharomyces cerevisiae. Mol Cell Biol (1985) 0.75
Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene (1977) 114.87
Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci U S A (1972) 57.06
Transformation of yeast. Proc Natl Acad Sci U S A (1978) 46.46
Analysis of restriction fragments of T7 DNA and determination of molecular weights by electrophoresis in neutral and alkaline gels. J Mol Biol (1977) 33.84
Yeast transformation: a model system for the study of recombination. Proc Natl Acad Sci U S A (1981) 26.54
High-frequency transformation of yeast: autonomous replication of hybrid DNA molecules. Proc Natl Acad Sci U S A (1979) 26.51
Transformation in yeast: development of a hybrid cloning vector and isolation of the CAN1 gene. Gene (1979) 16.95
Transformation of yeast by a replicating hybrid plasmid. Nature (1978) 16.35
Isolation of yeast DNA. Methods Cell Biol (1975) 12.35
Nucleotide sequence of the yeast plasmid. Nature (1980) 7.64
Gene conversion between duplicated genetic elements in yeast. Nature (1981) 7.14
Effects of the RAD52 Gene on Recombination in SACCHAROMYCES CEREVISIAE. Genetics (1980) 6.07
Plasmid identification using specific endonucleases. Mol Gen Genet (1974) 3.59
Recombination within the yeast plasmid 2mu circle is site-specific. Cell (1982) 3.48
Replication of each copy of the yeast 2 micron DNA plasmid occurs during the S phase. Cell (1979) 3.00
Recombination of dispersed repeated DNA sequences in yeast. Science (1980) 2.97
The CAN1 locus of Saccharomyces cerevisiae: fine-structure analysis and forward mutation rates. Genetics (1979) 2.53
Inheritance of the 2 micrometer m DNA plasmid from Saccharomyces. Genetics (1977) 2.01
Inheritance of spontaneous mutability in yeast. Genetics (1971) 2.00
Chimeric plasmids for cloning of deoxyribonucleic acid sequences in Saccharomyces cerevisiae. J Bacteriol (1979) 1.39
Replication in vitro of the 2-micrometer DNA plasmid of yeast. Proc Natl Acad Sci U S A (1979) 1.33
Genetic complementation of the Saccharomyces cerevisiae leu2 gene by the Escherichia coli leuB gene. Mol Cell Biol (1981) 1.21
The basis of instability of a revertant of the gal3 insertion of Escherichia coli. J Mol Biol (1978) 0.84
Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence. Clin Otolaryngol (2009) 5.33
A neural basis for general intelligence. Science (2000) 4.49
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med (1975) 3.36
The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bull World Health Organ (1968) 2.96
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae. Bull World Health Organ (1969) 2.77
Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan. Bull World Health Organ (1968) 2.71
OMFS: Gender imbalance? Br Dent J (2016) 2.56
Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev (1977) 2.50
B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens. J Exp Med (1977) 2.44
Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med (1982) 2.39
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27
Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. Aliment Pharmacol Ther (2013) 2.26
Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection. Aliment Pharmacol Ther (2014) 2.22
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
The effect of magnesium sulphate infusion on the incidence and severity of emergence agitation in children undergoing adenotonsillectomy using sevoflurane anaesthesia. Anaesthesia (2013) 2.06
Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc (1999) 1.90
Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J Immunol (1976) 1.84
Transcriptional regulation of the mosquito vitellogenin gene via a blood meal-triggered cascade. Gene (2001) 1.81
Mechanism of repression of methionine biosynthesis in Escherichia coli. I. The role of methionine, s-adenosylmethionine, and methionyl-transfer ribonucleic acid in repression. Mol Gen Genet (1973) 1.73
Isolation and functional analysis of a human 70,000-dalton heat shock protein gene segment. Proc Natl Acad Sci U S A (1985) 1.70
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol (2001) 1.69
A rapid procedure for DNA sequencing using transposon-promoted deletions in Escherichia coli. Gene (1985) 1.67
Theta-sensitive cell and erythropoiesis: identification of a defect in W/Wv anemic mice. Science (1977) 1.67
Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest (2000) 1.66
Unreamed interlocking nailing in open fractures of tibia. J Orthop Surg (Hong Kong) (2004) 1.60
Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest (1994) 1.58
The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI. Nature (1997) 1.58
Efficient transformation of the yellow fever mosquito Aedes aegypti using the piggyBac transposable element vector pBac[3xP3-EGFP afm]. Insect Biochem Mol Biol (2001) 1.55
Engineering blood meal-activated systemic immunity in the yellow fever mosquito, Aedes aegypti. Proc Natl Acad Sci U S A (2000) 1.53
Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis. Aliment Pharmacol Ther (2012) 1.53
Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis (1994) 1.52
Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J (1997) 1.52
Breast clinic referrals: can mastalgia be managed in primary care? Ir J Med Sci (2014) 1.51
Lymphocytes binding and T cell mitogenic properties of group A streptococcal lipoteichoic acid. J Immunol (1979) 1.49
Should we consent for bowel evisceration as a potential complication of hysterectomy? J Obstet Gynaecol (2008) 1.47
Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Oncogene (2007) 1.46
Pathogenic mechanisms in pulmonary fibrosis: collagen-induced migration inhibition factor production and cytotoxicity mediated by lymphocytes. J Clin Invest (1976) 1.46
Lyb-7, a new B cell alloantigen controlled by genes linked to the IgCH locus. J Immunol (1979) 1.43
The gamma and epsilon subunits of the CD3 complex inhibit pre-Golgi degradation of newly synthesized T cell antigen receptors. J Cell Biol (1990) 1.42
Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol (1973) 1.41
Hepatitis-C virus antibodies (anti HCV) in haemodialyzed vs non-dialyzed patients. J Pak Med Assoc (1994) 1.40
Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J (1999) 1.40
High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia (2007) 1.39
Specific murine B-cell activation by synthetic single-and double-stranded polynucleotides. J Exp Med (1973) 1.37
Bacterial complications of primary varicella in children. Clin Infect Dis (1996) 1.35
Cholera toxoid boosts serum Escherichia coli antitoxin in humans. Infect Immun (1974) 1.35
Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis. I. Partial characterization. J Exp Med (1974) 1.35
Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-Mental State Examination. Neurology (2000) 1.35
The perception and practice of traditional medicine in the treatment of cancers and inflammations by the Hausa and Fulani tribes of Northern Nigeria. J Ethnopharmacol (2007) 1.34
The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of eczema. Br J Dermatol (2013) 1.34
The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. J Infect Dis (1970) 1.34
Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation. Bull World Health Organ (1973) 1.31
Blastogenic response of Toxoplasma-infected mouse spleen cells to T- and B-cell mitogens. Clin Exp Immunol (1975) 1.31
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response. Lupus (1999) 1.31
Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. Br J Cancer (1984) 1.31
Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines. J Exp Med (1973) 1.30
Use of microculture plates and the multiple automated sample harvester for in vitro microassay of bacterial toxins. Appl Microbiol (1974) 1.30
Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbiol Immunol (1994) 1.29
Role of accessory cells in B cell activation. II. The interaction of B cells with accessory cells results in the exclusive activation of an Lyb5+ B cell subpopulation. J Immunol (1980) 1.29
Partial trisomy 14q-- and pseudoxanthoma elasticum. Clin Genet (1973) 1.27
Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med (2011) 1.26
Distinct B cell subpopulations differ in their genetic requirements for activation by T helper cells. Immunol Rev (1982) 1.26
Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet (2005) 1.24
Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein alpha-subunit chimeras. Yeast (2000) 1.24
Plasma and spinal-fluid blocking factor in SSPE. N Engl J Med (1973) 1.23
Risk factors for squamous cell carcinoma of the oesophagus in women: a case-control study. Br J Cancer (2001) 1.23
Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors (1996) 1.21
Helium-neon laser treatment transforms fibroblasts into myofibroblasts. Am J Pathol (1990) 1.21
Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod (1994) 1.20
Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens. J Exp Med (1979) 1.19
Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol (2000) 1.19
Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics (1998) 1.18
Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan. Int J Tuberc Lung Dis (2011) 1.18
How far investigations for occult metastases in breast cancer aid the clinician. Clin Oncol (R Coll Radiol) (1991) 1.17
Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production. J Clin Invest (1975) 1.16
Molecular typing of methicillin-resistant Staphylococcus aureus strains by PCR-RFLP of SPA gene: a reference laboratory perspective. Indian J Med Microbiol (2009) 1.15
Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab Invest (1998) 1.15
The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther (2014) 1.14
Induction of terminal deoxynucleotidyl transferase and Lyt antigens with thymosin: identification of multiple subsets of prothymocytes in mouse bone marrow and spleen. Proc Natl Acad Sci U S A (1981) 1.13
Identification of two forms of an endogenous murine retroviral env gene linked to the Rmcf locus. J Virol (1987) 1.13
T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides. Ann N Y Acad Sci (1979) 1.12
Problems in breast pathology. Major Probl Pathol (1979) 1.12
Mutants of Escherichia coli defective in the degradation of guanosine 5'-triphosphate, 3'-diphosphate (pppGpp). Mol Gen Genet (1979) 1.12
Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant (2009) 1.11
Response of CBA/N x DBA2/F1 mice to Nocardia asteroides. Infect Immun (1982) 1.11
Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med (1999) 1.10
Studies on non-H-2-linked lymphocyte-activating determinants. II. Nonexpression of Mls determinants in a mouse strain with an X-linked B lymphocyte immune defect. J Immunol (1976) 1.10
Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. J Clin Invest (1998) 1.10
Studies on the transfer of protective immunity with lymphoid cells from mice immune to malaria sporozoites. J Immunol (1978) 1.10
Control of fetal lung development in the rabbit. Arch Dis Child (1973) 1.10
Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment. Ann Oncol (2003) 1.10
Contribution of Lyb 5+ and Lyb 5- B cells to the primary and secondary phosphocholine-specific antibody response. J Immunol (1983) 1.09
A small-molecule, tight-binding inhibitor of the integrin alpha(4)beta(1) blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am J Respir Crit Care Med (2000) 1.09
Report of the 1966-67 cholera vaccine trial in rural East Pakistan. Bull World Health Organ (1972) 1.08